IP Library Granted Patent US 8,679,060
Granted Patent B2
US 8,679,060 · App. 12/817,031 · Granted Mar 25, 2014

Infusion pump system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,060
App. No.
12/817,031
Granted
Mar 25, 2014
Kind
B2
Abstract

An infusion pump system is described that increases patient comfort and convenience. The infusion pump system includes an infusion site interface that is releasably connected to an infusion pump body, and has no tubing associated between the infusion site interface and the pump body. The infusion pump body may include a carrier frame that may be adhered to the skin of a user.

Claims (16)

1. A method of operating an infusion pump system, comprising:

adhering an infusion site interface structure to a skin surface, the infusion site interface structure comprising: a frame with a lower surface facing toward the skin surface and an upward facing surface that is opposite the lower surface, a soft cannula coupled to the frame and extending below the lower surface of the frame for insertion subcutaneously through the skin surface to at least partially define a fluid path, and a septum arranged in the fluid path and coupled to the frame in a position above the upward facing surface of the frame; and

releasably connecting an infusion pump device to the frame of the infusion site interface structure adhered to the skin such that the infusion pump device is mechanically coupled to the frame of the infusion site interface structure and a piercing member of the infusion pump device penetrates the septum of the infusion pump device, through the penetrated septum of the infusion site interface structure, and through the soft cannula inserted subcutaneously through the skin surface;

causing the infusion pump device to dispense medicine into a user's body via the fluid path from the medicine reservoir housed in the infusion pump device, through the penetrated septum of the infusion site interface structure, and through the soft cannula inserted subcutaneously through the skin surface;

disconnecting and reconnecting the infusion pump device to the infusion site interface structure so that the fluid path is broken and re-established without replacement of the infusion site interface structure.

2. The method of claim 1 , wherein the step of releasably connecting the infusion pump device to the frame of the infusion site interface structure comprises forming a direct connection between the infusion pump device and the infusion site interface structure such that the fluid path is free of tubing.

3. The method of claim 1 , wherein the step of releasably connecting an infusion pump device to the frame of the infusion site interface structure comprises positioning the infusion pump device over the upward facing surface of the frame of the infusion site interface.

4. The method of claim 1 , wherein the piercing member of the infusion pump device comprises a needle that penetrates the septum of the infusion site interface structure.

5. The method of claim 4 , wherein the needle of the infusion pump device extends downwardly through an upper face of the septum such that the needle extends generally perpendicular to the skin surface when the needle penetrates the septum of the infusion site interface structure.

6. The method of claim 5 , wherein the frame of the infusion site interface structure comprises an inner ring hub that carriers the septum and an outer wall that is spaced apart from the inner ring hub and surrounds the inner ring hub.

7. The method of claim 6 , wherein the soft cannula is rigidly attached to the inner ring hub of the frame of the infusion site interface structure.

8. The method of claim 7 , wherein during the step of releasably connecting an infusion pump device to the frame of the infusion site interface structure, the needle of the infusion pump device is aligned with the inner ring hub of the frame of the infusion site interface structure.

9. The method of claim 1 , wherein the step of disconnecting and reconnecting the infusion pump device to the infusion site interface structure comprises temporarily detaching the infusion pump device from the infusion site interface structure while the infusion site interface structure is maintained on the skin surface.

10. The method of claim 1 , wherein the infusion pump device is mechanically coupled to the frame of the infusion site interface structure using a detent fit.

11. The method of claim 1 , wherein the infusion pump device is mechanically coupled to the frame of the infusion site interface structure using an insert-and-rotate fit.

12. The method of claim 1 , further comprising using a leak detection mechanism of the infusion pump system for a determination that the fluid path is compromised by a leak.

Assignments (20)
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 062900/0001 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2016
From: ASANTE SOLUTIONS, INC.
To: ASANTE LLC
Reel/Frame 039871/0771 →
CHANGE OF NAME Recorded Aug 26, 2016
From: M2 GROUP HOLDINGS, INC.
To: ASANTE SOLUTIONS, INC.
Reel/Frame 039833/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2016
From: ASANTE LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 039827/0060 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2016
From: MERNOE, MORTEN; CAUSEY, JAMES; WENGER, MITCHELL; ESTES, MARK C.
To: M2 MEDICAL A/S
Reel/Frame 039540/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2016
From: M2 MEDICAL A/S
To: M2 GROUP HOLDINGS, INC.
Reel/Frame 039540/0913 →